163 related articles for article (PubMed ID: 30305465)
21. The potential effect of ultra-long insulin degludec on glycemic variability.
Rodacki M; Carvalho RM; Zajdenverg L
Diabetes Res Clin Pract; 2017 Nov; 133():92-103. PubMed ID: 28918342
[TBL] [Abstract][Full Text] [Related]
22. Clinical use of insulin degludec.
Vora J; Cariou B; Evans M; Gross JL; Harris S; Landstedt-Hallin L; Mithal A; Rodriguez MR; Meneghini L
Diabetes Res Clin Pract; 2015 Jul; 109(1):19-31. PubMed ID: 25963320
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of a porcine insulin zinc suspension in diabetic dogs.
Graham PA; Nash AS; McKellar QA
J Small Anim Pract; 1997 Oct; 38(10):434-8. PubMed ID: 9358402
[TBL] [Abstract][Full Text] [Related]
24. Effect of insulin dosage on glycemic response in dogs with diabetes mellitus: 221 cases (1993-1998).
Hess RS; Ward CR
J Am Vet Med Assoc; 2000 Jan; 216(2):217-21. PubMed ID: 10649757
[TBL] [Abstract][Full Text] [Related]
25. Insulin therapy in cats with diabetes mellitus.
Moise NS; Reimers TJ
J Am Vet Med Assoc; 1983 Jan; 182(2):158-64. PubMed ID: 6298164
[TBL] [Abstract][Full Text] [Related]
26. A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON).
Mathieu C; Rodbard HW; Cariou B; Handelsman Y; Philis-Tsimikas A; Ocampo Francisco AM; Rana A; Zinman B;
Diabetes Obes Metab; 2014 Jul; 16(7):636-44. PubMed ID: 24443830
[TBL] [Abstract][Full Text] [Related]
27. Comparison of glucose fluctuations between day- and night-time measured using a continuous glucose monitoring system in diabetic dogs.
Mori A; Kurishima M; Oda H; Saeki K; Arai T; Sako T
J Vet Med Sci; 2013 Jan; 75(1):113-7. PubMed ID: 22971722
[TBL] [Abstract][Full Text] [Related]
28. The effect of Insulin Degludec on glycemic control in diabetic cats over a 12-month period.
Oda H; Mori A; Sako T
J Vet Med Sci; 2020 Jun; 82(6):695-698. PubMed ID: 32307342
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and pharmacodynamics of porcine insulin zinc suspension in eight diabetic dogs.
Fleeman LM; Rand JS; Morton JM
Vet Rec; 2009 Feb; 164(8):232-7. PubMed ID: 19234324
[TBL] [Abstract][Full Text] [Related]
30. Glargine insulin for treatment of naturally occurring diabetes mellitus in dogs.
Hess RS; Drobatz KJ
J Am Vet Med Assoc; 2013 Oct; 243(8):1154-61. PubMed ID: 24094263
[TBL] [Abstract][Full Text] [Related]
31. A randomized crossover study of the efficacy and safety of switching from insulin glargine to insulin degludec in children with type 1 diabetes.
Urakami T; Mine Y; Aoki M; Okuno M; Suzuki J
Endocr J; 2017 Feb; 64(2):133-140. PubMed ID: 27746408
[TBL] [Abstract][Full Text] [Related]
32. Insulin degludec/insulin aspart produces a dose-proportional glucose-lowering effect in subjects with type 1 diabetes mellitus.
Heise T; Nosek L; Klein O; Coester H; Svendsen AL; Haahr H
Diabetes Obes Metab; 2015 Jul; 17(7):659-64. PubMed ID: 25772444
[TBL] [Abstract][Full Text] [Related]
33. Use of insulin glargine in dogs with diabetes mellitus.
Fracassi F; Boretti FS; Sieber-Ruckstuhl NS; Reusch CE
Vet Rec; 2012 Jan; 170(2):52. PubMed ID: 22008227
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of insulin degludec three times a week versus insulin glargine once a day in insulin-naive patients with type 2 diabetes: results of two phase 3, 26 week, randomised, open-label, treat-to-target, non-inferiority trials.
Zinman B; DeVries JH; Bode B; Russell-Jones D; Leiter LA; Moses A; Johansen T; Ratner R;
Lancet Diabetes Endocrinol; 2013 Oct; 1(2):123-31. PubMed ID: 24622318
[TBL] [Abstract][Full Text] [Related]
35. Intermediate-acting insulin preparations: NPH and lente.
Deckert T
Diabetes Care; 1980; 3(5):623-6. PubMed ID: 7192205
[TBL] [Abstract][Full Text] [Related]
36. [Experience of using biosulin P and biosulin H for the treatment of diabetes mellitus].
Dedov II; Balabolkin MI
Ter Arkh; 2004; 76(1):65-8. PubMed ID: 15108443
[No Abstract] [Full Text] [Related]
37. A randomized trial comparing the rate of hypoglycemia--assessed using continuous glucose monitoring--in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study).
Danne T; Philotheou A; Goldman D; Guo X; Ping L; Cali A; Johnston P
Pediatr Diabetes; 2013 Dec; 14(8):593-601. PubMed ID: 23730996
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of a purified porcine insulin zinc suspension for managing diabetes mellitus in dogs.
Monroe WE; Laxton D; Fallin EA; Richter KP; Santen DR; Panciera DL; Towell TL; Williams KA; Hart JR; Hill S; Finkler MR; Shinn JS
J Vet Intern Med; 2005; 19(5):675-82. PubMed ID: 16231711
[TBL] [Abstract][Full Text] [Related]
39. [Insulin degludec--a new basal insulin for the treatment of type 1 and type 2 diabetes].
Gallwitz B; Haak T
MMW Fortschr Med; 2013 Oct; 155 Suppl 3():76-82. PubMed ID: 24930317
[TBL] [Abstract][Full Text] [Related]
40. Randomized controlled trial of insulin detemir versus NPH for the treatment of pregnant women with diabetes.
Herrera KM; Rosenn BM; Foroutan J; Bimson BE; Al Ibraheemi Z; Moshier EL; Brustman LE
Am J Obstet Gynecol; 2015 Sep; 213(3):426.e1-7. PubMed ID: 26070699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
